1 / 41

APPROACH TO PATIENTS WITH AMENORRHEA

APPROACH TO PATIENTS WITH AMENORRHEA. Enrico Gil C. Oblepias, MD, FPOGS Associate Professor University of the Philippines Philippine General Hospital. INTRODUCTION. Menstruation is the: physical herald to physiologic capacity for conceiving monthly prepares the uterus for implantation

aviv
Télécharger la présentation

APPROACH TO PATIENTS WITH AMENORRHEA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. APPROACH TO PATIENTS WITH AMENORRHEA Enrico Gil C. Oblepias, MD, FPOGS Associate Professor University of the Philippines Philippine General Hospital

  2. INTRODUCTION Menstruation is the: • physical herald to physiologic capacity for conceiving • monthly prepares the uterus for implantation • shedding of the uterine lining at the end of the reproductive cycle

  3. INTRODUCTION Amenorrhea is the: • absence of menstruation • is met with some extent with anxiety.

  4. FIRST STEP Ask when the last menses were. This will systematically cut down differentials to a more manageable and economical number. Dichotomously dividing these into primary and secondary cases of amenorrhea.

  5. AMENORRHEA Never had menses? Primary amenorrhea: Failure of menarche to occur when expected in relation to the onset of pubertal development. No menarche by age 16 years with signs of pubertal development. No onset of pubertal development by age 14 years.

  6. AMENORRHEA Used to have menses? Secondary amenorrhea: Absence of menstruation for 3 or more months in a previously menstruating women of reproductive age.

  7. HPO AXIS • The menstrual cycle is actually 3 different inter-related cycles synchronously taking place at the same time. • These are: • the ovarian cycle • the hormonal cycle • (3) the endometrial cycle.

  8. HPO AXIS Amenorrhea is only a manifestation of the problem. Problem may be endocrinologic or embryologic: +/- secondary sexual characteristics +/- female internal genitalia

  9. PRIMARY AMENORRHEA Quick Rules to Remember No breast – no or low estrogen < FSH, LH – hypothalamic or pituitarian > FSH, LH– ovarian No uterus 46XX –Mullerian agenesis 46XY – Pseudohermaphroditism

  10. PHYSICAL EXAM

  11. PHYSICAL EXAM

  12. PRIMARY AMENORRHEA Category 1: Breasts Absent and Uterus Present – Think low estrogen, check FSH A. Gonadal failure: High FSH (hypergonadotropic) 1. 45X (Turner’s Syndrome) 2. 46X; abnormal X (Deletion Disorders) 3. Mosaicism (X/XX, X/XX/XXX) 4. Pure XX (PGD, 46XX or Perrault syndrome ) 5. 17 alpha-hydroxylase deficiency (46XX)

  13. PRIMARY AMENORRHEA Category 1: Breasts Absent and Uterus Present – Think low estrogen, check FSH B. CNS-hypothalamic pituitary disorders: Low FSH (hypogonadotropic) 1. CNS lesions 2. Inadequate GnRH – Kallmann’s 3. Isolated gonadotrophin insufficiency

  14. Category 1: Breasts Absent and Uterus Present Serum FSH High Low or Normal Hypergonadotropic Hypogonadism Hypogonadotropic Hypogonadism Blood Pressure CT scan, Prolactin Normal High Normal High Karyotype 45 X 46 X, abn X Mosaic Pure gondal Dysgenesis w/ 26 XX or 46 XY 17 alpha Hydroxylase Deficiency (Congenital Adrenal Hyperplasia) Non-prolactin Secreting tumor of the CNS Inadequate GnRH Pituitary Adenoma

  15. PRIMARY AMENORRHEA Category 2: Breasts Present and Uterus Absent – Think (+) estrogen, (?) MIF: check karyotype • Mayer Rokitansky Kuster Hauser Syndrome (46XX) vaginal agenesis and no uterus caused by random birth defect • Androgen Insensitivity Syndrome (46 XY) cells are not receptive to testosterone thus patient has intra-abdominal testes and no uterus or vagina

  16. Category 2: Breasts Present and Uterus Absent Karyotyping Testosterone 46XX Normal 46XY High Congenital Absence of the Uterus Androgen Insensitivity (Testicular Feminization)

  17. PRIMARY AMENORRHEA Category 3: Breasts Absent and Uterus Absent – This is rare. – Think low estrogen and (+) MIF: check a karyotype A. 17, 20-Desmolase deficiency (46 XY) B. 17 alpha hydroxylase deficiency (46 XY) C. Pure XY (PGD, 46XY or Swyer’s Syndrome) D. Agonadism

  18. Category 3: Breasts Absent and Uterus Absent Karyotype (XY) Laparoscopy testes absent testes present Enzyme Deficiency: 17, 20 desmolase 17 - Hydroxylase (with XY karyotype) Agonadism

  19. PRIMARY AMENORRHEA Category 4: Breasts Present and Uterus Present –Think (+) estrogen, (-) MIF – Evaluate like secondary amenorrhea A. Hypothalamic causes B. Pituitary causes C. Ovarian causes D. Uterine causes and outflow tract causes (?)

  20. Category 4: Breasts Present and Uterus Present Prolactin High Normal Hypothalamic causes Pituitary causes Ovarian causes Uterine causes Outflow tract disorders Pituitary Lesion (Prolactinoma)

  21. Cryptomenorrhea Despite the absence of menstrual flow, withdrawal bleeding does take place – albeit concealed. intermittent abdominal pain possible difficulty with micturition possible lower abdominal swelling • imperforate hymen • transverse vaginal septum with functioning uterus • isolated vaginal agenesis with functioning uterus • isolated cervical agenesiswith functioning uterus

  22. Cryptomenorrhea

  23. CNS; HP Disorder Gonadal Failure Androgen Sensitivity Syndrome Mullerian Agenesis Evaluation of Primary Amenorrhea History and physical examination completed for a patient with primary amenorrhea Secondary sexual characteristics present No Yes Measure FSH and LH levels Perform ultrasonography of uterus FSH > 20 IU/ L and LH > 40 IU/ L Uterus absent or abnormal Uterus present or normal FSH and LH < 5 IU/ L Hypergonadotropic hypogonadism Karyotype analysis Outflow obstruction Hypogonadotropic hypogonadism Yes No Karyotype analysis 46, XY 46, XX Evaluate for secondary amenorrhea Imperforate hymen or transverse vaginal septum

  24. SECONDARY AMENORRHEA

  25. Pregnancy In women of reproductive age, pregnancy is the most common cause of secondary amenorrhea. The reality of this must be ascertained before any intervention is instituted for non-obstetric amenorrhea.

  26. SECONDARY AMENORRHEA Give them a progestin challenge to induce menstruation. Dichotomously dividing secondary cases of amenorrhea to those with and without estrogen priming of the endometrium

  27. PROGESTERONE CHALLENGE TEST (PCT) 10mg of progesterone orally for 5- 10 days A withdrawal bleed occurring within ten days of a progesterone challenge is a positive result and a diagnosis of anovulation may be established.

  28. PROGESTERONE CHALLENGE TEST (PCT) POSITIVE • HP Dysfunction • Hyperthyroidism • PCOS NEGATIVE • Hyperprolactenemia • Hypothyroidism • Hypopituitarism • POF • Asherman’s

  29. POSITIVE PCT Hypothalamic-Pituitary Dysfunction • can result from any condition that disturbs the HPO axis • the immediate cause is a decrease or lack of GnRH pulses • this may be idiopathic, or may be the result of stress or weight loss • anorexia (most common cause of secondary amenorrhea in teenagers)

  30. POSITIVE PCT Hyperthyroidism • although the sex binding globulin is increased, testosterones and estrogen are also increased • relatively, compared to normal, there is more circulating free estrogen and free testosterone with testosterone being converted further peripherally to estrogen • the elevated estrogen concentration then leads to state similar to anovulation

  31. POSITIVE PCT Polycystic Ovaries Syndrome • a persistent anovulatory state • result in a steady supply of estrogen and the lack of progesterone’s anti-estrogen effect • brings about continuous stimulation of the receptive endometrium • the most common endocrinopathy in reproductive-age women and amenorrhea or oligomenorrhea is quite frequent

  32. NEGATIVE PCT Hyperprolactenemia • elevated levels of prolactin inhibits GnRH by increasing the release of dopamine from the arcuate nucleus of the hypothalamus • inhibiting gonadal steroidogenesis, which is the hypoestrogenism • may be caused by either compression of the pituitary or excess production from a pituitary gland adenoma

  33. NEGATIVE PCT Hypothyroidism • alpha subunits of LH, FSH, and TSH are identical and only vary in their beta subunits • a cross-reaction between the TSH, FSH, LH leads to a negative feedback suppressing the release of FSH and LH affecting follicular maturation and ovulation • the endometrium fails to go through the proliferation and secretory phases resulting in the absence of menstruation. • stimulation of the anterior pituitary leading to an increased release of prolactin has also been considered

  34. NEGATIVE PCT Hypopituitarism • caused by necrosis of the anterior pituitary due to blood loss and hypovolemic shock • Sheehan’s syndrome if obstetric in origin • Simmond’s syndrome if non-obstetric • FSH and LH become deficient and lead to the lack of menstruation

  35. NEGATIVE PCT Premature Ovarian Failure • is an end organ phenomenon • occurring before the age of 40 • characterized by (1) lack of ovarian response to tropic stimulation; (2) lack of gonadal negative feed-back; (3) elevated circulating levels of FSH and LH • pathogenesis of this disorder has not been determined • it is possible that there is an autoimmune basis for this

  36. NEGATIVE PCT Asherman’s Syndrome • is characterized by the formation of scar tissues obliterating the endometrial cavity that prevents the occurrence of normal menstrual periods • occurs most frequently after a vigorous scraping during completion curettage • can also result from other pelvic surgeries like cesarean sections, myomectomies, pelvic irradiation, schistosomiasis and genital tuberculosis • cervical stenosis after a cone biopsy or LEEP

  37. STEP 1: Evaluation of Secondary Amenorrhea Medroxyprogesterone acetate (5-10 mg BID for 5 days) No Uterine Bleeding Uterine Bleeding Step 3 Step 2

  38. STEP 2: Evaluation of Secondary Amenorrhea Uterine bleeding: positive response LH Normal or Low High (>25mIU/ml) TSH Hypothalamic Dysfunction (drug, stress or exercise, weight loss) Polycystic Ovarian Syndrome Hyperthyroidism Testosterone (Ovarian) DHEAS (Adrenal) Ultrasound Prolactin High Normal Induce bleeding monthly with progestins, oral contraceptives; Dexamethasone Spironolactone Induce uterine bleeding monthly with DMPA 10 mg/day for 12 days Work-up for hyperprolactinemia

  39. STEP 3: Evaluation of Primary Amenorrhea No uterine bleeding: negative response FSH Normal or Low High (>30 mIU/ml) Negative Estrogen Progesterone test Premature Ovarian Failure TSH (hypothyroidism) Prolactin (hyperprolactinemia) CT scan of CNS Asherman’s Syndrome If < 25 years old; karyotype If < 35 years old; antinuclear antibodies, 24 hr urine cortisol test Hypothalamic Pituitary Disorder HSG Hysteroscopy

  40. GENERAL PRINCIPLES OF MANAGEMENT OF AMENORRHEA • attempts to restore ovulatory function by treating underlying cause • if not possible, HRT (estrogen and progesterone) is given to hypo-estrogenic amenorrheic women • periodic progestogen may be given instead for anovulatory women • if Y chromosome is present gonadectomy is indicated • create outflow tract or at least a sexually functional vagina • many cases require frequent re-evaluation

  41. CONCLUSION Amenorrhea may be caused by any of the many differentials discussed herein. The appropriate management of this will depend on the accurate diagnosis of the etiology. A logical approach makes it possible to do it systematically and in a shorter period of time. Some conditions may be correctable while others are not. Objectives of treatment may vary, but the underlying cause in each must be addressed at the very least every time.

More Related